|
|
The spill-over effect of Vodafone’s battle with Indian tax authorities may prove costly for several other deal makers. The Central Board of Direct Taxes (CBDT) has reopened about 400 cases of big and mid-sized transactions that took place during the past six to seven years. According to sources close to the development, the cases include foreign corporates and PE firms selling stakes of companies based in India, and not paying any capital gains tax. One of the first such cases that the tax department is currently probing is Montreal-based Alcan Inc’s selling of the controlling stake in Indian Aluminium Company (Indal) to Hindalco Industries seven years ago, sources in the finance ministry told SundayET. Significantly, there were around 300 PE deals clocked in India in 2006 alone. The tax department had earlier slapped a notice on Vodafone Essar, demanding $2 billion as capital gains tax over its $1-billion acquisition of a majority stake in Hutchison Essar, India’s fourth largest mobile telephone company. The case is now locked in the Bombay High Court. […]
Global private equity investors are expected to increase their exposure to India, say fund managers. Many new funds are also looking to tap the growth opportunities. The UK-based Actis Capital plans to launch a $1 billion India infrastructure fund shortly. The fund already has $700 million investments in this country. The new fund would be launched early next year, Mr Steven Enderby, Partner South Asia of Actis LLP, said at the sidelines of a conference organised by the Asia Private Equity and Venture Forum here on Tuesday. Another overseas private equity investor, Evolvence Advisory Service will be launching a $300 million second India dedicated ‘fund of funds.’ It already has invested $400 million in India through “Evolvence India Fund.” The fund has seen a return of 80 per cent in the past three years, said Mr Jay V. Jegannathan, Managing Director. The fund has exposure in areas such as real estate, healthcare and infrastructure. […]
Leading the pack is ICICI Ventures (I Ven), which acquired US-based Radiant Research for about $65 million in June this year. The fund is now looking at similar investments in South America, Eastern Europe and the Asia Pacific. It has roped in the top five Indian pharmaceutical companies as partners, including Wockhardt and Dr Reddy’s. Along with these companies, I Ven will purchase CROs worldwide and integrate them as one single entity called Swiss Biosciences. Similarly, Kotak Private Equity is doing the rounds of investment bankers to build something similar. An investment banker, who did not wish to be named, said, “Kotak PE wants to build a chain of clinical research organisation by acquiring companies in the US, Europe and India.” Sources say UTI Venture Funds is also contemplating the same. […]
Venture capitalists invested more than $777 million in 57 deals for entrepreneurial companies in India during the first three quarters of 2007, according to the Quarterly India Venture Capital Report published for the first time today by Dow Jones VentureOne and Ernst & Young. This was nearly five times the $158 million invested during the first nine months of 2006 and more than twice the annual investment record of $320 million set in 2005. The report covers venture capital investment specifically, which Dow Jones VentureOne defines as growth capital made available to entrepreneurial companies in exchange for ownership in the form of private securities. These investments are often seen as shorter-term and do not include private equity investments such as leveraged buyouts or mezzanine and debt financing. The report showed 54% of all venture deals in India were for companies in the Information Technology (IT) categories, as 31 rounds were completed in the first nine months of the year, accounting for more than $327 million worth of investment. […]
Quite contrary to investment guru Warren Buffet’s term ‘deal flippers’ for private equity companies, ET Intelligence Group concludes that private equity money is good money. In 1999, Warburg Pincus picked up a stake in an emerging company called Bharti Tele-Ventures. By ’01, it had invested close to $300 million in a company yet to make a profit. Sceptics sniggered and there was a time when the company’s stock price plunged lower than the issue price, However, Warburg remained confident and finally, the bet paid off. When Warburg sold its stake, it walked away with a profit of $1.3 billion. It was a landmark deal, in that private equity (PE) became a force to reckon with. From $1.1 billion invested in 60 deals in ’04, to $7.9 billion in 302 deals in ’06, PE has grown by a whopping 600%. In the first half of ’07, 200 deals worth $6.82 billion had been announced. It’s likely that the total investment will touch $10 billion by the year-end. Blackstone, Carlyle, Farallon, Chrys Capital, Morgan Stanley and Temasek are some companies that have committed millions to the India Growth story. Some have entered as venture capitalists, which generally focus on early stage investments, while others are pure PE buyouts. PE has come a long way from providing fuel (funds) to the fiery growth of India Inc. It helps investee companies with a whole host of activities — from forging strategic alliances to assisting in corporate governance, from providing management advice to budgeting. To understand the PE impact on India Inc, ET Intelligence Group decided to scrutinise the performance of companies receiving PE funding. We did this by tracking deals concluded before January ’07, since it’s too early to comment on companies that received money in ’07. We analysed data for approximately 100 listed companies, spread across sectors like gems and jewellery, tea, shipping, aviation, edible oil and garments, to name a few. We compared the performance of companies receiving PE funds with those of their peers in the corresponding ET sectoral indices that did not get any such funds. […]
India's realty industry will grow at a fast clip of 30 percent over the next 10 years, offer 20-25 percent returns and secure foreign investment worth $30 billion, says a study by a leading industry lobby. 'The total size of investments in the domestic real estate sector is likely to be $102 billion,' says the study released Sunday by the Associated Chambers of Commerce and Industry of India (Assocham). 'At present, the domestic real estate market is expected to be $14 billion, in which the foreign direct investment contribution is estimated to be at $5-5.5 billion,' the study adds. 'The only problem that the real estate sector is currently confronting is with approvals for setting up townships, as a number of central and state agencies are involved,' said chamber president Venugopal N. Dhoot. […]
The government is likely to allow private equity (PE) funds and venture capitalists (VCs) to be part of the consortia that bid for infrastructure projects. At present, these entities can only participate indirectly in these projects by committing funds to one of the bidders. “Given that financing of the infrastructure sector is essential to sustain the growth story, the move to enable PE/VC funds to invest in these projects is in the right direction,” said a finance ministry source. Sebi-registered VC funds and PE firms are barred from bidding for infrastructure projects, as they do not meet conventional qualifications like gross revenue, net worth or net cash accruals. The move is in line with the recommendations of the infrastructure finance committee headed by Deepak Parekh. The Centre is understood to have agreed in principle to the proposal and is examining the impact. The move would encourage these investors to participate at the inception stage, the source added. […]
Small and mid-size pharma companies focused on outsourcing seem to have caught the attention of investors, if the recent investments by private equity (PE) players in the sector are any indication. PE firms such as ICICI Venture, Citi Venture Group and Sequoia Capital have put their money in upcoming pharma units that are focussed on outsourcing. Sequoia Capital on Wednesday invested Rs 100 crore in Hyderabad-based pharma and biotech research firm GVK Biosciences. Earlier, the PE firm had also picked up around 18% stake in clinical research firm Sai Advantium for around Rs 50 crore. Two other clinical research firms Radiant Research and SIRO Clinpharm have also received PE fund infusement from ICICI, 3i and Kotak, respectively, earlier this year. Says Sequoia Capital MD Sandeep Singhal: “The growth in small companies and companies which are focussed on a specialisation, is much faster than the leading established players. We are looking at investing in companies which are looking to become leading players in the future rather than the stable companies with lesser risks and lesser rewards.” Adds PwC associate director Pharmaceutical and Life Sciences Practice Sujay Shetty: “This is a new breed of companies which has entered the new space of high potential contract manufacturing and outsourcing. Outsourcing is the biggest growth area in the pharma sector and the PE investments in such firms will continue.” […]
India has scored over China in terms of total private equity (PE) investments received from the United States over the last eight years, but China is well ahead of India in terms of PE investments this calendar. According to a study by Thomson Financial, “India appears to be emerging as a new favourite among global PE investors. Over the last eight years, it has received $2.51 billion in PE investments compared to $2.4 billion in China. Nevertheless, India still lags in terms of growth as PE investments have grown at a CAGR of 26.7 per cent over the last seven years.” Thomson Financial is an arm of the Thomson Corporation, one of the world’s leading information companies, focused on providing integrated information solutions to business and professional customers. PE investments from the US to China is growing at a compounded annual growth rate of 36.5 per cent (over the last eight years), but private equity investments have grown by 108 per cent (through October 2007) compared to a year ago, the Thomson study said. US PE firms are among the largest investors and play a pivotal role in the growth of such investments in the two Asian countries. Since 2000, these US firms have constituted 96.8 per cent of all PE investments in China and 73.4 per cent in India. […]
Private equity (PE) investors have become bearish on returns, according to a half-year survey conducted by private equity advisory group Deloitte Corporate Finance Services India Pvt. Ltd among 40 PE firms across September and October. A majority (52%) expected returns to decrease in the next six months compared with 23% in their survey for the first half of 2007. One survey respondent, who was not named, qualified this concern by saying: “Investments made two or three years ago that exit in the next six months will do very well. More recent vintages will see more muted returns.” Also, one in five respondents expected a decrease in new funds being raised for India. No respondent expected a slowdown in investment activity The slight cooling down in PE market sentiment largely comes from the rise in the number of PE funds in India— a phenomenon that has raised company valuations. Increasing competition has also caused PE firms to focus more on the factors that differentiate them as companies look for more than money. Despite the outlook on returns, none of the respondents expected a slowdown in investment activity (65% expected increased activity versus 84% in the last survey). […]
|
Post your messages.Please refrain from posting offensive messages. IndiaPE accepts no liability for the consequences of your reliance on these postings and messages.
|